The calculation runs in your browser; no data is sent or stored. The result is for information only and does not replace assessment by your doctor.
What is the Steno Type 1 Risk Engine and who is it for?
The Steno Type 1 Risk Engine is the model published in 2016 by the Steno Diabetes Center in Copenhagen for patients with type 1 diabetes [1]. It was built on data from 4306 adults followed between 2001 and 2013 and validated in a further 2119 patients from Denmark [1]. The model estimates the risk of a first cardiovascular event, fatal or non-fatal, over the next 5 and 10 years. The event includes ischemic heart disease, ischemic stroke, heart failure and peripheral artery disease [1].
The model is meant for adults with type 1 diabetes without known cardiovascular disease [1]. Calculators built for the general population or for type 2 diabetes generally do not take into account diabetes duration and glycemic control. The Steno calculator uses ten variables: age, sex, diabetes duration, systolic blood pressure, LDL cholesterol, HbA1c, albuminuria, glomerular filtration rate, smoking and regular exercise [1]. For type 2 diabetes use the SCORE2-Diabetes calculator or PREVENT, both available on this site.
What do the percentage and the three risk categories mean?
The figure is the probability of a first cardiovascular event over the next 10 years, and the second figure shows the same probability at 5 years [1]. The official calculator divides the risk into three categories: low under 10%, medium from 10% to under 20%, and high from 20% upwards. The thresholds come from the NICE guideline on cardiovascular prevention, used in the United Kingdom [2].
The 2026 ADA/EASD consensus for adults with type 1 diabetes recommends a statin over the age of 40 [3]. Between 20 and 39, a statin is considered when the 10-year risk, estimated with a calculator suited to type 1, exceeds 10% [3]. For such a risk, the LDL cholesterol target in primary prevention is under 70 mg/dL (1.8 mmol/L), with a reduction of at least 50% from the starting value [3]. Your doctor sets the treatment plan, from the estimated risk and the other clinical data.
How accurate is the Steno calculator result for me?
In the derivation cohort, the model ranked the risk correctly with a C-index of 0.826, and in the Danish validation of 0.803, which is very good [1]. In Scotland, in 27527 patients, it kept its discrimination but overestimated the number of events by about 27% [4]. In Italy, in 456 adults followed for 8.5 years, it separated the three risk categories well [5]. In Hong Kong, in Chinese patients with type 1 diabetes, the calibration was good [6].
Your figure is therefore an estimate for a Northern European population, not an individual prediction. Outside Denmark, the real risk may be lower compared with the one shown [4]. The 2023 ESC guideline recommends for type 1 diabetes a Scottish–Swedish model, with results close to Steno but with more variables [4] [7]. Use the result for the conversation with your doctor, not instead of it.
What data do I need and how do I enter it?
You need a recent set of laboratory results, with LDL cholesterol, HbA1c, creatinine and the urine albumin-to-creatinine ratio. The glomerular filtration rate is calculated from creatinine, for example with the eGFR calculator on this site. Albuminuria is chosen by the albumin-to-creatinine ratio [1]. It is normal under 30 mg/g (3 mg/mmol), moderately increased from 30 to 299 mg/g (3–30 mg/mmol) and severely increased from 300 mg/g (30 mg/mmol). Regular exercise means at least 3.5 hours of physical activity per week [1].
The calculator accepts LDL cholesterol in mg/dL or mmol/L and HbA1c in percent or mmol/mol. The model was built in adults, so under 18 the calculator stops. If you have had a heart attack, a stroke or another cardiovascular disease, the model does not apply. The result appears as soon as all the fields are filled in.
References
- Prediction of first cardiovascular disease event in type 1 diabetes mellitus: the Steno Type 1 Risk Engine. Circulation. 2016;133(11):1058-1066. PubMed
- Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline CG181. NICE. 2014, updated 2023. NICE
- The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2026 Sep 16. Online ahead of print. PubMed
- Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia. 2021;64(9):2001-2011. PubMed
- Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study. Diabetes Res Clin Pract. 2022;190:110001. PubMed
- Validation of the ST1RE risk engine in Chinese with type 1 diabetes and comparison with the JADE, RECODe, and UKPDS risk scores. J Diabetes Investig. 2026;17(7):1163-1171. PubMed
- 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043-4140. PubMed